K2 Therapeutics
Boston · Founded 2024
About K2 Therapeutics
K2 Therapeutics creates advanced antibody-based therapies focused on difficult multi-pass membrane targets to address unmet disease needs.
Company Facts
- Founded: 2024
- Legal name: K2 Therapeutics, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: k2-tx.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/k2-therapeutics-8374416 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.